Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "CAPA (Corrective and Preventative Action) Training Course (Dec 5, 2025)" training has been added to ResearchAndMarkets.com's offering. In today's highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback